Browsing Category
Lipids
Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in…
Abstract
Amphotericin B (AmB) is used to treat Allergic Bronchopulmonary Aspergillosis (ABPA) caused by Aspergillus fumigatus. AmB is available in oral and injectable forms but has limitations, resulting in low levels of AmB in the lungs. We formulated AmB using Nanostuctured Lipid Carriers (NLCs)…
Read More...
Read More...
Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in…
Abstract
The present study focuses on the development and optimization of a solid self-microemulsifying drug delivery system (SSMEDDS) of Nateglinide, a poorly water-soluble antidiabetic drug, to enhance its oral bioavailability. Initially, a liquid
SMEDDS was formulated using Capmul MCM as the…
Read More...
Read More...
The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary…
Abstract
Lipid nanoparticles (LNPs) are of significant interest as delivery systems for various RNA therapeutics, not least due to their outstanding success in applications including the COVID-19 vaccines and the siRNA therapeutic Onpattro®. As LNPs consist of different lipids, the lipid…
Read More...
Read More...
Liposomes containing sorbitan monolaurate incorporated in hydroxyethylcellulose hydrogels for…
Abstract
In this work, liposomes composed of soy phosphatidylcholine (SPC) and cholesterol (CHOL), in addition to sorbitan monolaurate (span 20), a skin penetration enhancer, were incorporated into hydroxyethylcellulose (HEC) hydrogels to optimize the topical administration of 5-fluorouracil (5-FU)…
Read More...
Read More...
Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for…
Abstract
Alzheimer's disease (AD) is a complex neurodegenerative that affects over 55 million people worldwide, a number expected to double by 2050 due to aging populations. This growing prevalence imposes immense societal and economic burdens on healthcare systems and caregivers. AD is challenging…
Read More...
Read More...
Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and…
Abstract
Nowadays, the use of unfractionated low molecular weight heparins through intravenous and subcutaneous routes has been limited by several delivery challenges. These include pharmacological activity fluctuations, bleeding issues, and numerous manufacturing restrictions. To address these …
Read More...
Read More...
Efficacy of memantine prodrug microemulsion in a Preclinical model of tendinopathy
Abstract
Tendinopathy is a complex musculoskeletal pathology characterized by pain and dysfunction in the tendon. Tendinopathy management includes pharmacological treatments, which, however, have numerous side effects and low efficacy. New pharmacological approaches are essential to overcome these…
Read More...
Read More...
Solid lipid discs from water-in-oil emulsion as controlled release delivery systems of highly…
Abstract
Solid lipid systems (SLSs) are widely employed to control the release of highly hydrophilic drugs, and they are, in general, obtained by solubilizing or suspending the drug within melted lipid excipients. This work proposes an advantageous strategy to modulate the drug release of a…
Read More...
Read More...
Development and Evaluation of Sublingual Tablet of Lercanidipine by Solid Dispersion Method
Abstract
The purpose of this study was to develop and evaluate a sublingual tablet of lercanidipine hydrochloride for the direct compression method of treating hypertension by using a solid dispersion technique. The dihydropyridine calcium-channel blocker lercanidipine Hydrochloride is used to…
Read More...
Read More...
Anticancer Activity of Phospholipid-Dexibuprofen Conjugates Loaded in Nanostructured Lipid Carriers
Abstract
Purpose: In our work, we focused on the development of nanostructured lipid carriers (NLCs) loaded with dexibuprofen (DXI) and their application for cancer therapy by proposing the binding of phospholipids with this non-steroidal anti-inflammatory drug (NSAID) to obtain new delivery…
Read More...
Read More...